Dimetapp Allergy Liquigel Side Effects
Generic Name: brompheniramine, brompheniramine maleate, dexbrompheniramine maleate
Please note - some side effects for Dimetapp Allergy Liquigel may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects by Body System - for Healthcare Professionals
Applies to: compounding powder; injectable solution; oral capsule; oral capsule, extended release; oral liquid; oral suspension, extended release; oral tablet; oral tablet, chewable, extended release; oral tablet, extended release
Nervous system side effects have included central nervous system (CNS) depression, resulting in drowsiness and sedation in nearly 50% of patients treated. This effect has often been transient and ceased with continued use. Motor skills have be impaired and patients should be advised to avoid tasks which require attention. Patients should also avoid concomitant use with alcohol and other sedative-hypnotic drugs. Dyskinesias have rarely been reported following chronic use of brompheniramine.
A few cases of dyskinesias and tremors, often of the face, have been reported in patients whose chronic use of brompheniramine extended over a period of up to 10 years. Some of these cases were only partially relieved by discontinuation of the drug. Haloperidol was successful in relieving symptoms in these patients. Spasmodic torticollis has been reported in a child given brompheniramine over an eight month period.
Gastrointestinal side effects have include nausea, dry mouth and constipation.
Cardiovascular effects of brompheniramine have included hypotension, tachycardia, and palpitations.
Ocular side effects have included blurred vision, diplopia, and dry eyes due to anticholinergic effects.
Genitourinary side effects have included dysuria, urinary hesitancy, decrease in urine flow, and, in rare cases, acute urinary retention.
Hematologic side effects have included rare cases of hemolytic anemia, thrombocytopenia, and agranulocytosis.Top
- Dimetapp Allergy Liquigel Concise Consumer Information (Cerner Multum)
- Brompheniramine Professional Patient Advice (Wolters Kluwer)
- brompheniramine 12-hour sustained-release tablets MedFacts Consumer Leaflet (Wolters Kluwer)
- Brompheniramine Maleate, Dexbrompheniramine Maleate Monograph (AHFS DI)
- Brovex suspension MedFacts Consumer Leaflet (Wolters Kluwer)
- Brovex CT chewable tablets MedFacts Consumer Leaflet (Wolters Kluwer)
- Lodrane 24 24-hour sustained-release capsules MedFacts Consumer Leaflet (Wolters Kluwer)
- VaZol liquid MedFacts Consumer Leaflet (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.